Characterization and protective property of Brucella abortus cydC and looP mutants

Clinical and Vaccine Immunology

Volumn 21, Issue 11, 2014, Pages 1573-1580

  Truong, Quang Lam ^a,b   Cho, Youngjae ^a,b   Barate, Abhijit Kashinath ^a,b   Kim, Suk ^a,b   Hahn, Tae Wook ^a,b  

^a Kangwon National University   (South Korea)

^b Gyeongsang National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; CYDC BACTERIAL VACCINE; LOOP BACTERIAL VACCINE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; ABC TRANSPORTER; ATP-BINDING PROTEIN, BACTERIA; BACTERIAL PROTEIN; BRUCELLA VACCINE; CARRIER PROTEIN; LIVE VACCINE; TRANSPOSON; VIRULENCE FACTOR;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL SURVIVAL; BACTERIAL VIABILITY; BACTERIAL VIRULENCE; BACTERIUM MUTANT; BRUCELLA ABORTUS; BRUCELLOSIS; COLONY FORMING UNIT; CONTROLLED STUDY; CYDC GENE; FEMALE; GENE FUNCTION; IMMUNE RESPONSE; IMMUNIZATION; IN VITRO STUDY; IN VIVO STUDY; INFECTION PREVENTION; LOOP GENE; MOUSE; NONHUMAN; PH; SPLEEN WEIGHT; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; DEFICIENCY; EPITHELIUM CELL; GENE DELETION; GENE EXPRESSION REGULATION; GENETIC COMPLEMENTATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; MACROPHAGE; MICROBIOLOGY; PROCEDURES; TRANSPOSON; VACCINATION; VIRULENCE;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BACTERIAL PROTEINS; BRUCELLA ABORTUS; BRUCELLA VACCINE; CARRIER PROTEINS; CELL LINE; DNA TRANSPOSABLE ELEMENTS; EPITHELIAL CELLS; FEMALE; GENE DELETION; GENETIC COMPLEMENTATION TEST; HUMANS; INJECTIONS, INTRAPERITONEAL; MACROPHAGES; MICE, INBRED BALB C; MUTAGENESIS, INSERTIONAL; VACCINATION; VACCINES, ATTENUATED; VIRULENCE; VIRULENCE FACTORS;

EID: 84914666390     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00164-14     Document Type: Article

References (40)

1. Corbel MJ. 1997. Brucellosis: an overview. Emerg. Infect. Dis. 3:213-221. http://dx.doi.org/10.3201/eid0302.970219.
2. Roop RM, Bellaire BH, Valderas MW, Cardelli JA. 2004. Adaptation of the brucellae to their intracellular niche. Mol. Microbiol. 52:621-630. http://dx.doi.org/10.1111/j.1365-2958.2004.04017.x.
3. Ficht TA. 2003. Intracellular survival of Brucella: defining the link with persistence. Vet. Microbiol. 92:213-223. http://dx.doi.org/10.1016/S0378 -1135(02)00367-X.
4. Ashford DA, di Pietra J, Lingappa J, Woods C, Noll H, Neville B, Weyant R, Bragg SL, Spiegel RA, Tappero J, Perkins BA. 2004. Adverse events in humans associated with accidental exposure to the livestock brucellosis vaccine RB51. Vaccine 22:3435-3439. http://dx.doi.org/10.1016/j.vaccine.2004.02.041.
5. Schurig GG, Sriranganathan N, Corbel MJ. 2002. Brucellosis vaccines: past, present and future. Vet. Microbiol. 90:479-496. http://dx.doi.org/10.1016/S0378-1135(02)00255-9.
6. Kim S, Watarai M, Kondo Y, Erdenebaatar J, Makino S, Shirahata T. 2003. Isolation and characterization of mini-Tn5Km2 insertion mutants of Brucella abortus deficient in internalization and intracellular growth in HeLa cells. Infect. Immun. 71:3020-3027. http://dx.doi.org/10.1128/IAI.71.6.3020-3027.2003.
7. Alcantara RB, Read RD, Valderas MW, Brown TD, Roop RM. 2004. Intact purine biosynthesis pathways are required for wild-type virulence of Brucella abortus 2308 in the BALB/c mouse model. Infect. Immun. 72:4911-4917. http://dx.doi.org/10.1128/IAI.72.8.4911-4917.2004.
8. Kohler S, Foulongne V, Ouahrani-Bettache S, Bourg G, Teyssier J, Ramuz M, Liautard JP. 2002. The analysis of the intramacrophagic virulome of Brucella suis deciphers the environment encountered by the pathogen inside the macrophage host cell. Proc. Natl. Acad. Sci. U.S A. 99:15711-15716. http://dx.doi.org/10.1073/pnas.232454299.
9. Endley S, McMurray D, Ficht TA. 2001. Interruption of the cydB locus in Brucella abortus attenuates intracellular survival and virulence in the mouse model of infection. J. Bacteriol. 183:2454-2462. http://dx.doi.org/10.1128/JB.183.8.2454-2462.2001.
10. Gonzalez D, Grillo MJ, De Miguel MJ, Ali T, Arce-Gorvel V, Delrue RM, Conde-Alvarez R, Munoz P, Lopez-Goni I, Iriarte M, Marin CM, Weintraub A, Widmalm G, Zygmunt M, Letesson JJ, Gorvel JP, Blasco JM, Moriyon I. 2008. Brucellosis vaccines: assessment of Brucella melitensis lipopolysaccharide rough mutants defective in core and Opolysaccharide synthesis and export. PLoS One 3:e2760. http://dx.doi.org /10.1371/journal.pone.0002760.
11. Ko J, Splitter GA. 2003. Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans. Clin. Microbiol. Rev. 16:65-78. http://dx.doi .org/10.1128/CMR.16.1.65-78.2003.
12. Goldman BS, Gabbert KK, Kranz RG. 1996. The temperature-sensitive growth and survival phenotypes of Escherichia coli cydDC and cydAB strains are due to deficiencies in cytochrome bd and are corrected by exogenous catalase and reducing agents. J. Bacteriol. 178:6348-6351.
13. Poole RK, Hatch L, Cleeter MW, Gibson F, Cox GB, Wu G. 1993. Cytochrome bd biosynthesis in Escherichia coli: the sequences of the cydC and cydD genes suggest that they encode the components of an ABC membrane transporter. Mol. Microbiol. 10:421-430. http://dx.doi.org/10.1111/j.1365-2958.1993.tb02673.x.
14. Poole RK, Gibson F, Wu G. 1994. The cydD gene product, component of a heterodimeric ABC transporter, is required for assembly of periplasmic cytochrome c and of cytochrome bd in Escherichia coli. FEMS Microbiol. Lett. 117:217-223. http://dx.doi.org/10.1111/j.1574-6968.1994.tb06768.x.
15. Fischer H, Glockshuber R. 1994. A point mutation within the ATPbinding site inactivates both catalytic functions of the ATP-dependent protease La (Lon) from Escherichia coli. FEBS Lett. 356:101-103. http: //dx.doi.org/10.1016/0014-5793(94)01244-X.
16. Yang H, Hamada K, Terashima H, Izuta M, Yamaguchi-Sihta E, Kondoh O, Satoh H, Miyazaki M, Arisawa M, Miyamoto C, Kitada K. 1996. A point mutation within each of two atp-binding motifs inactivates the functions of elongation factor 3. Biochim. Biophys. Acta 1310:303-308. http://dx.doi.org/10.1016/0167-4889(95)00179-4.
17. McQuiston JR, Schurig GG, Sriranganathan N, Boyle SM. 1995. Transformation of Brucella species with suicide and broad host-range plasmids. Methods Mol. Biol. 47:143-148.
18. White PG, Wilson JB. 1951. Differentiation of smooth and nonsmooth colonies of brucellae. J. Bacteriol. 61:239-240.
19. Watarai M, Kim S, Erdenebaatar J, Makino S, Horiuchi M, Shirahata T, Sakaguchi S, Katamine S. 2003. Cellular prion protein promotes Brucella infection into macrophages. J. Exp. Med. 198:5-17. http://dx.doi.org/10 .1084/jem.20021980.
20. Watarai M, Makino S, Fujii Y, Okamoto K, Shirahata T. 2002. Modulation of Brucella-induced macropinocytosis by lipid rafts mediates intracellular replication. Cell. Microbiol. 4:341-355. http://dx.doi.org/10.1046 /j.1462-5822.2002.00195.x.
21. Young J, Holland IB. 1999. ABC transporters: bacterial exportersrevisited five years on. Biochim. Biophys. Acta 1461:177-200. http://dx.doi.org/10.1016/S0005-2736(99)00158-3.
22. Fath MJ, Kolter R. 1993. ABC transporters: bacterial exporters. Microbiol. Rev. 57:995-1017.
23. Toyoda T, Okano S, Shibata Y, Abiko Y. 2010. Oxidative stress induces phosphorylation of the ABC transporter, ATP-binding protein, in Porphyromonas gingivalis. J. Oral Sci. 52:561-566. http://dx.doi.org/10.2334 /josnusd.52.561.
24. Deyrup AT, Krishnan S, Cockburn BN, Schwartz NB. 1998. Deletion and site-directed mutagenesis of the ATP-binding motif (P-loop) in the bifunctional murine ATP-sulfurylase/adenosine 5=-phosphosulfate kinase enzyme. J. Biol. Chem. 273:9450-9456. http://dx.doi.org/10.1074/jbc.273.16.9450.
25. Bowler MW, Montgomery MG, Leslie AG, Walker JE. 2006. How azide inhibits ATP hydrolysis by the F-ATPases. Proc. Natl. Acad. Sci. U.S.A. 103: 8646-8649. http://dx.doi.org/10.1073/pnas.0602915103.
26. Hong S, Pedersen PL. 2008. ATP synthase and the actions of inhibitors utilized to study its roles in human health, disease, and other scientific areas. Microbiol. Mol. Biol. Rev. 72:590-641. http://dx.doi.org/10.1128/MMBR.00016-08.
27. Goldman BS, Kranz RG. 2001. ABC transporters associated with cytochrome c biogenesis. Res. Microbiol. 152:323-329. http://dx.doi.org/10.1016/S0923-2508(01)01203-7.
28. Cook GM, Poole RK. 2000. Oxidase and periplasmic cytochrome assembly in Escherichia coli K-12: CydDC and CcmAB are not required for haem-membrane association. Microbiology 146:527-536.
29. Pittman MS, Robinson HC, Poole RK. 2005. A bacterial glutathione transporter (Escherichia coli CydDC) exports reductant to the periplasm. J. Biol. Chem. 280:32254-32261. http://dx.doi.org/10.1074/jbc.M503075200.
30. Cruz-Ramos H, Cook GM, Wu G, Cleeter MW, Poole RK. 2004. Membrane topology and mutational analysis of Escherichia coli CydDC, an ABC-type cysteine exporter required for cytochrome assembly. Microbiology 150:3415-3427. http://dx.doi.org/10.1099/mic.0.27191-0.
31. Jimenez de Bagues MP, Loisel-Meyer S, Liautard JP, Jubier-Maurin V. 2007. Different roles of the two high-oxygen-affinity terminal oxidases of Brucella suis: cytochrome c oxidase, but not ubiquinol oxidase, is required for persistence in mice. Infect. Immun. 75:531-535. http://dx.doi.org/10.1128/IAI.01185-06.
32. Sun YH, de Jong MF, den Hartigh AB, Roux CM, Rolan HG, Tsolis RM. 2012. The small protein CydX is required for function of cytochrome bd oxidase in Brucella abortus. Front. Cell. Infect. Microbiol. 2:47. http://dx.doi.org/10.3389/fcimb.2012.00047.
33. Cook GM, Membrillo-Hernandez J, Poole RK. 1997. Transcriptional regulation of the cydDC operon, encoding a heterodimeric ABC transporter required for assembly of cytochromes c and bd in Escherichia coli K-12: regulation by oxygen and alternative electron acceptors. J. Bacteriol. 179:6525-6530.
34. Way SS, Sallustio S, Magliozzo RS, Goldberg MB. 1999. Impact of either elevated or decreased levels of cytochrome bd expression on Shigella flexneri virulence. J. Bacteriol. 181:1229-1237.
35. Winstedt L, Yoshida K, Fujita Y, von Wachenfeldt C. 1998. Cytochrome bd biosynthesis in Bacillus subtilis: characterization of the cydABCD operon. J. Bacteriol. 180:6571-6580.
36. Stevens MG, Olsen SC, Pugh GW, Jr, Brees D. 1995. Comparison of immune responses and resistance to brucellosis in mice vaccinated with Brucella abortus 19 or RB51. Infect. Immun. 63:264-270.
37. Jimenez de Bagues MP, Elzer PH, Jones SM, Blasco JM, Enright FM, Schurig GG, Winter AJ. 1994. Vaccination with Brucella abortus rough mutant RB51 protects BALB/c mice against virulent strains of Brucella abortus, Brucella melitensis, and Brucella ovis. Infect. Immun. 62:4990-4996.
38. Kahl-McDonagh MM, Elzer PH, Hagius SD, Walker JV, Perry QL, Seabury CM, den Hartigh AB, Tsolis RM, Adams LG, Davis DS, Ficht TA. 2006. Evaluation of novel Brucella melitensis unmarked deletion mutants for safety and efficacy in the goat model of brucellosis. Vaccine 24: 5169-5177. http://dx.doi.org/10.1016/j.vaccine.2006.04.005.
39. Ko J, Gendron-Fitzpatrick A, Ficht TA, Splitter GA. 2002. Virulence criteria for Brucella abortus strains as determined by interferon regulatory factor 1-deficient mice. Infect. Immun. 70:7004-7012. http://dx.doi.org /10.1128/IAI.70.12.7004-7012.2002.
40. Kim S, Kurokawa D, Watanabe K, Makino S, Shirahata T, Watarai M. 2004. Brucella abortus nicotinamidase (PncA) contributes to its intracellular replication and infectivity in mice. FEMS Microbiol. Lett. 234:289-295. http://dx.doi.org/10.1111/j.1574-6968.2004.tb09546.x.